Anavex Life Sciences
AVXL
$3.44
Share price
1.47%
Change (1 day)
-57.74%
Change (1 year)
Categories
Anavex Life Sciences (AVXL) - Net assets
Net assets on the balance sheet as of December 2023 : $0.13 B
According to Anavex Life Sciences
's latest financial reports the company has $0.13 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Anavex Life Sciences - Net assets on balance sheet (from 2005 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-09-30 | $0.14 B | -0.45% |
| 2022-09-30 | $0.14 B | -5.52% |
| 2021-09-30 | $0.15 B | 453.73% |
| 2020-09-30 | $27.23 M | 34.24% |
| 2019-09-30 | $20.28 M | -9.1% |
| 2018-09-30 | $22.32 M | -7.97% |
| 2017-09-30 | $24.25 M | 284.49% |
| 2016-09-30 | $6.3 M | -50.75% |
| 2015-09-30 | $12.8 M | 6549.68% |
| 2014-09-30 | $0.19 M | -107.82% |
| 2013-09-30 | $-2.47 M | -14.33% |
| 2012-09-30 | $-2.88 M | 151.68% |
| 2011-09-30 | $-1.15 M | -61.41% |
| 2010-09-30 | $-2.97 M | -23.27% |
| 2009-09-30 | $-3.86 M | 68.3% |
| 2008-09-30 | $-2.3 M | 395.6% |
| 2007-09-30 | $-0.47 M | 2881.78% |
| 2006-09-30 | $-0.02 M | -40.39% |
| 2005-09-30 | $-0.03 M | -201.62% |
| 2004-09-30 | $0.02 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Ligand Pharmaceuticals LGND | $0.70 B | 416.99% | 🇺🇸 USA |
 Corcept Therapeutics
CORT | $0.50 B | 273.75% | 🇺🇸 USA |
 Palatin Technologies PTN | -$11.39 M | -108.40% | 🇺🇸 USA |
 BioCryst Pharmaceuticals
BCRX | -$0.46 B | -436.00% | 🇺🇸 USA |